Axsome Therapeutics Announces $225 Million Term Loan Facility with Hercules Capital
Non-dilutive committed capital extends cash runway into at least 2024Facility strengthens balance sheet through anticipated commercial launches of Axsome’s two […]
Glory Star Jointly Releases White Paper on China’s Video Content-Driven E-Commerce Industry Together With iResearch
BEIJING, Sept. 29, 2020 (GLOBE NEWSWIRE) — Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) (“Glory Star” or the […]
Affimed to Present at Jefferies Virtual Cell Therapy Summit
Heidelberg, Germany, September 29, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate […]
Utah District Court Rules in Favor of Overstock in Class Action Securities Case
SALT LAKE CITY, Sept. 29, 2020 (GLOBE NEWSWIRE) — Overstock.com, Inc. (NASDAQ:OSTK) announced today that the United States District Court […]
Orgenesis Announces Agreement to Acquire Koligo Therapeutics, a Leader in Personalized Cell Therapies
Acquisition to support accelerated commercialization of Koligo’s KYSLECEL®, a personalized islet cell therapy available in the U.S. for chronic and recurrent […]
Airtel And Radware Partner to Offer Cloud Security Services to Businesses in India
MAHWAH, N.J., Sept. 29, 2020 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a leading provider of cyber security and application delivery […]
UTStarcom Announces New Product in its SkyFlux Converged Packet Transport Platform
HANGZHOU, China, Sept. 29, 2020 (GLOBE NEWSWIRE) — UTStarcom (“UTStarcom” or the “Company”) (NASDAQ:UTSI), a global telecommunications infrastructure provider, announced […]
Mimecast Announces Integration with Theta Lake
LEXINGTON, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) — Mimecast Limited (NASDAQ: MIME), a leading email security and cyber resilience company, […]
Aurora Joins Open:FactSet Marketplace, Giving Users More Access to Insightful Data on Mobile App Usage in China
SHENZHEN, China, Sept. 29, 2020 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora” or the “Company”), a leading mobile developer […]
Celyad Oncology Announces Clinical Trial Collaboration to Evaluate CYAD-101 with KEYTRUDA® (pembrolizumab) in Patients with Microsatellite Stable mCRC
MONT-SAINT-GUIBERT, Belgium, Sept. 29, 2020 (GLOBE NEWSWIRE) — Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused […]
